StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) stock

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.42−0.06 (-4.05%)

Close on Nov 17, 2026Market cap $53.14MP/E –Yield –

Earnings

Tenax Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 9, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.31
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Tenax Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 9, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026before the open––-$0.31Release
Q2 FY2026ended Jun 30, 2026Jul 31, 2026before the open–––Release
Q1 FY2026ended Mar 31, 2026May 12, 2026before the open–––Release
Q4 FY2025ended Dec 31, 2025Mar 10, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025after the close–––Release
Q2 FY2025ended Jun 30, 2025Aug 13, 2025after the close––-$0.27Release
Q1 FY2025ended Mar 31, 2025May 14, 2025after the close–––Release
Q4 FY2024ended Dec 31, 2024Mar 25, 2025after the close–––Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024before the open––$0.19Release
Q2 FY2024ended Jun 30, 2024Aug 13, 2024after the close––-$1.83Release
Q1 FY2024ended Mar 31, 2024May 14, 2024before the open––-$3.12Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Tenax Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Tenax Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Tenax Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. Update
  4. News
  5. News
  6. Results
  7. News
  8. Results
  9. News
  10. Results
  11. News
  12. Results
  13. News
  14. Results
  15. Results

See a number that looks wrong?